Commission Regulation (EU) 2015/845 of 27 May 2015 amending Annexes II and III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for azoxystrobin, chlorantraniliprole, cyantraniliprole, dicamba, difenoconazole, fenpyroximate, fludioxonil, glufosinate-ammonium, imazapic, imazapyr, indoxacarb, isoxaflutole, mandipropamid, penthiopyrad, propiconazole, pyrimethanil, spirotetramat and trinexapac in or on certain products
Proposed act with possible EEA relevance
Act under scrutiny by EEA EFTA
Draft Joint Committee Decision (JCD) under consideration
Entry into force of Joint Committee Decision (JCD) pending
Incorporated into the EEA Agreement and in force
Incorporated into the EEA Agreement but no longer in force
Legal status
EU legal act incorporated into the EEA Agreement by a Joint Committee Decision (JCD) Area (EEA Agreement)
II Technical Regulations, Standards, Testing and Certification
II.XII Foodstuffs
Joint committee decision (JCD)
297/2015 In force in the EEA
Yes Legal documents
Commission Regulation (EU) 2015/845 of 27 May 2015 amending Annexes II and III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for azoxystrobin, chlorantraniliprole, cyantraniliprole, dicamba, difenoconazole, fenpyroximate, fludioxonil, glufosinate-ammonium, imazapic, imazapyr, indoxacarb, isoxaflutole, mandipropamid, penthiopyrad, propiconazole, pyrimethanil, spirotetramat and trinexapac in or on certain products
Reglugerð framkvæmdastjórnarinnar (ESB) 2015/845 frá 27. maí 2015 um breytingu á II. og III. viðauka við reglugerð Evrópuþingsins og ráðsins (EB) nr. 396/2005 að því er varðar hámarksgildi leifa fyrir asoxýstróbín, klórantranilípról, sýantranilípról, díkamba, dífenókónasól, fenpýroxímat, flúdíoxóníl, glúfosínatammóníum, imasapik, imasapýr, indoxakarb, ísoxaflútól, mandíprópamíð, penþíópýrað, própíkónasól, pýrimetaníl, spírótetramat og trínexapak í eða á tilteknum afurðum
Verordnung (EU) 2015/845 der Kommission vom 27. Mai 2015 zur Änderung der Anhänge II und III der Verordnung (EG) Nr. 396/2005 des Europäischen Parlaments und des Rates hinsichtlich der Höchstgehalte an Rückständen von Azoxystrobin, Chlorantraniliprol, Cyantraniliprol, Dicamba, Difenoconazol, Fenpyroximat, Fludioxonil, Glufosinatammonium, Imazapic, Imazapyr, Indoxacarb, Isoxaflutol, Mandipropamid, Penthiopyrad, Propiconazol, Pyrimethanil, Spirotetramat und Trinexapac in oder auf bestimmten Erzeugnissen
Kommisjonsforordning (EU) 2015/845 av 27. mai 2015 om endring av vedlegg II og III til europaparlaments- og rådsforordning (EF) nr. 396/2005 med hensyn til grenseverdier for rester av azoksystrobin, klorantraniliprol, cyantraniliprol, dikamba, difenokonazol, fenpyroksimat, fludioksonil, ammoniumglufosinat, imazapik, imazapyr, indoksakarb, isoksaflutol, mandipropamid, pentiopyrad, propikonazol, pyrimetanil, spirotetramat og trineksapak i eller på visse produkter
History
12.12.2015
Adopted JCD confirmed entry into force date
12.12.2015
Compliance date in the EEA
11.12.2015
Adoption of Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement
16.10.2015
Draft Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement sent to Commission
27.05.2015
Adoption date in the EU
24.06.2015
Compliance date in the EU
Disclaimer: EEA-Lex is provided for information purposes only. The information is not guaranteed or promised to be current or complete and is not intended to replace any applicable legal sources.